Acceleron Pharma Inc. XLRN
Trading inactive
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | Delaware | 476100 | 0 | 476100 | 10 | 476100 | 7.3 % | 05/10/2021 |
| BEHZAD AGHAZADEH | United States | 476100 | 0 | 476100 | 10 | 476100 | 7.3 % | 05/10/2021 |
| Adage Capital Advisors, L.L.C. | Delaware | 0 | 1600469 | 0 | 0 | 1600469 | 5.09 % | 12/06/2014 |
| Adage Capital Partners GP, L.L.C. | Delaware | 0 | 1600469 | 0 | 0 | 1600469 | 5.09 % | 12/06/2014 |
| Adage Capital Partners, L.P. | Delaware | 0 | 1600469 | 0 | 0 | 1600469 | 5.09 % | 12/06/2014 |
| Phillip Gross | United States | 0 | 1600469 | 0 | 0 | 1600469 | 5.09 % | 12/06/2014 |
| Robert Atchinson | United States | 0 | 1600469 | 0 | 0 | 1600469 | 5.09 % | 12/06/2014 |
| 9.2%3 | Delaware | 0 | 26224352 | 0 | 26224352 | 26224352 | 9.2 % | 14/02/2014 |
| 9.2%3 | Delaware | 0 | 26224352 | 0 | 26224352 | 26224352 | 9.2 % | 14/02/2014 |
| 9.2%3 | Delaware | 0 | 26224352 | 0 | 26224352 | 26224352 | 9.2 % | 14/02/2014 |
| 9.2%3 | Delaware | 0 | 26224352 | 0 | 26224352 | 26224352 | 9.2 % | 14/02/2014 |
| 9.2%3 | Delaware | 0 | 26224352 | 0 | 26224352 | 26224352 | 9.2 % | 14/02/2014 |
| 9.2%3 | Delaware | 0 | 26224352 | 0 | 26224352 | 26224352 | 9.2 % | 14/02/2014 |
| OrbiMed Advisors LLC | Delaware | 0 | 2272819 | 0 | 2272819 | 2272819 | 8.02 % | 13/02/2014 |
| Advanced Technology Ventures VI, L.P. | Delaware | 0 | 25137832 | 0 | 25137832 | 2 | 3 % | 13/02/2014 |